GlassScriptPhysician profile
Melissa K Witt
NPI 1477200350
$799.28
in general payments reported to CMS, 2019-2025
9 companies · $65.85 in 2025
The $65.85 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $331 · 2024: $270 · 2025: $65.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $461.92 | 2022-2025 | |
| Pfizer INC. | $70.07 | 2022-2025 | |
| Smith+Nephew, INC. | $64.01 | 2023-2024 | Collagenase Santyl |
| Organogenesis INC. | $57.39 | 2024-2025 | Cygnus Dual |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.93 | 2022-2024 | Lifevest |
| Paratek Pharmaceuticals, INC. | $39.12 | 2023 | Nuzyra |
| Aroa Biosurgery Incorporated | $20.16 | 2023 | |
| Merck Sharp & Dohme LLC | $18.52 | 2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $15.16 | 2023 | Brilinta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Witt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.